DelistingJun 12, 2026, 04:37 PM
Adagio Medical receives Nasdaq delisting notice for bid price rule
AI Summary
Adagio Medical Holdings, Inc. received a notice from Nasdaq on June 12, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share for continued listing. The company has 180 calendar days, until December 9, 2026, to regain compliance by having its common stock close at or above $1.00 for at least ten consecutive trading days. Its stock will continue to trade on the Nasdaq Capital Market during this period, and the company is exploring options, including a potential reverse stock split.
Key Highlights
- Received Nasdaq notice on June 12, 2026, for non-compliance with Listing Rule 5550(a)(2).
- Minimum bid price was below $1.00 per share for 30 consecutive business days.
- Has 180 calendar days, until December 9, 2026, to regain compliance.
- Must close at or above $1.00 per share for at least ten consecutive trading days.
- Common stock continues to trade on Nasdaq Capital Market during compliance period.
- Company may pursue a reverse stock split if a second 180-day period is needed.
Price Impact
More from ADGM